Cite
A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial
MLA
Timothy S. C. Hinks, et al. “A Multi-Centre Open-Label Two-Arm Randomised Superiority Clinical Trial of Azithromycin versus Usual Care in Ambulatory COVID-19: Study Protocol for the ATOMIC2 Trial.” Trials, vol. 21, no. 1, Aug. 2020, pp. 1–8. EBSCOhost, https://doi.org/10.1186/s13063-020-04593-8.
APA
Timothy S. C. Hinks, Vicki S. Barber, Joanna Black, Susan J. Dutton, Maisha Jabeen, James Melhorn, Najib M Rahman, Duncan Richards, Daniel Lasserson, Ian D. Pavord, & Mona Bafadhel. (2020). A multi-centre open-label two-arm randomised superiority clinical trial of azithromycin versus usual care in ambulatory COVID-19: study protocol for the ATOMIC2 trial. Trials, 21(1), 1–8. https://doi.org/10.1186/s13063-020-04593-8
Chicago
Timothy S. C. Hinks, Vicki S. Barber, Joanna Black, Susan J. Dutton, Maisha Jabeen, James Melhorn, Najib M Rahman, et al. 2020. “A Multi-Centre Open-Label Two-Arm Randomised Superiority Clinical Trial of Azithromycin versus Usual Care in Ambulatory COVID-19: Study Protocol for the ATOMIC2 Trial.” Trials 21 (1): 1–8. doi:10.1186/s13063-020-04593-8.